%0 Journal Article
%T Hyperlipidemia medication management in patients admitted for a myocardial infarction
%A Shuster
%A Jerrica E.
%A Jeffres
%A Meghan N.
%A Barclay
%A Sean M.
%A Bhakta
%A Ragini
%J Pharmacy Practice (Internet)
%D 2011
%I Scientific Electronic Library Online
%R 10.4321/S1886-36552011000100005
%X objectives: the purpose of this study is to determine the percentage of patients admitted for acute myocardial infarction currently prescribed a statin, with low-density lipoprotein (ldl) <100 mg/dl, and high-density lipoprotein (hdl) <50 mg/dl for men and <55 mg/dl for women and evaluate their medication management with a focus on niacin initiation. methods: this was a retrospective study from 12/07 to 12/09, conducted at a private, community hospital. inclusion criteria required patients to have an acute myocaridal infarction (ami) icd-9 code, troponin >0.2 ng/dl and lipid panel performed within 96 hours of troponin. patients with a triglyceride level > 400 mg/dl were excluded. the residual risk population consisted of patients currently taking a statin with ldl <100 mg/dl and hdl <50/55 mg/dl. patients were excluded from the residual risk population if they were on niacin, had an allergy to or previously failed niacin therapy, or expired within 72 hours. results: a total of 553 patients experiencing an ami had lipid panels available for evaluation. the mean ldl was 97.3 ¡À 36.0 mg/dl, mean hdl was 33.5 ¡À 11.1 mg/dl, and mean triglycerides were 133.1 ¡À 71.3 mg/dl. the majority of patients (n=521, 94.2%) had an hdl < 50 or 55 mg/dl respective of gender. ninety-two (80.0%) residual risk patients had no change in their home lipid medications post ami. fifteen (13.0%) residual risk patients had their dose of statin medication increased. seven (6.1%) residual risk patients were initiated on niacin. conclusions: the study results confirm an existence of a residual risk population with nearly 25% of ami patients meeting the criteria. the results also confirm a low incidence of medication intervention in the residual risk population post ami (20.0%) regarding lipid therapy, including the initiation of niacin in only 6.1% of patients.
%K myocardial infarction
%K niacin
%K cholesterol
%K hdl
%K united states.
%U http://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S1886-36552011000100005&lng=en&nrm=iso&tlng=en